Valve-in-valve transcatheter aortic valve replacement had superior short-term outcomes than redo surgical aortic valve replacement, but comparable long-term outcomes.
Guidance is provided for cardiovascular specialists for the initiation and management of glucose-lowering therapies in patients with type 2 diabetes.
The double-blind EMPEROR-Reduced trial enrolled 3730 adults with HFrEF, with and without diabetes.
Poor health literacy is associated with worse heart failure outcomes.
NSAID treatment is associated with a significantly increased risk for cardiovascular and bleeding events in myocardial infarction.
Many patients recently recovered from COVID-19 infection have cardiac involvement.
The 6-minute walk test was found to have limited value for the identification of response to cardiac resynchronization therapy in patients with mild heart failure and left bundle branch block.
T end and Te standard deviation may represent noninvasive clinical markers to predict the risk for in-hospital mortality among patients with decompensated chronic heart failure.
Cardiac troponin may aid clinicians in determining stage classification and stratifying risk for myocardial injury among patients with COVID-19.
Placental abruption may be associated with an increased risk for heart failure, particularly among women with hypertensive disorders of pregnancy and preterm birth.